AETNA INC. for AETNA INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 8, 2011 | $902,453 | Replaced |
| 2nd Quarter - Amendment (this page) | Nov 4, 2011 | $902,453 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Capital loss carryback (No Bills yet) Interchange fee and application to debit card for FSA business; HR 2010/S. 1089 (eaxpand use of HSAs); HR 605/S. 312 (Repeal restriction on use of HSA/FSA for OTC Drugs).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLYN IOVINO | — |
| JONATHAN TOPODAS | — |
Retirement RET
Retiree health insurance (no bills yet); Seek clarification from CCIIO on application of ACA to Retiree- Only health plans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLYN IOVINO | — |
| JONATHAN TOPODAS | — |
Medicare/Medicaid MMM
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN B KELMAR | — |
| CHRISTINA NYQUIST | — |
| PETER RUBIN | — |
| GEOFFREY C SANDLER | — |
| MOLLY SCHILD | — |
| JONATHAN TOPODAS | — |
Insurance INS
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLYN IOVINO | — |
| STEVEN B KELMAR | — |
| CHRISTINA NYQUIST | — |
| ANDREW D PATZMAN | — |
| GEOFFREY C SANDLER | — |
| JONATHAN TOPODAS | — |
Health Issues HCR
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLYN IOVINO | — |
| STEVEN B KELMAR | — |
| CHRISTINA NYQUIST | — |
| PETER RUBIN | — |
| GEOFFREY C SANDLER | — |
| MOLLY SCHILD | — |
| JONATHAN TOPODAS | — |
Torts TOR
HR 5 (Medical Malpractice Liability Reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN TOPODAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.